Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
    • New Approvals
      • GI
      • GU
      • Lung Cancer
    • Tox Check
      • GI
      • GU
      • Lung Cancer
      • Breast Cancer
    • Treatment Algorithms
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Articles
    • Breast Cancer
    • GU Oncology
    • GI Oncology
    • Hematology
    • Lung Cancer
      • NSCLC
      • SCLC
  • Clinical Insights
    • Bladder Cancer
    • Lung Cancer
      • SCLC
      • NSCLC
  • Conferences
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
    • New Approvals
      • GI
      • GU
      • Lung Cancer
    • Tox Check
      • GI
      • GU
      • Lung Cancer
      • Breast Cancer
    • Treatment Algorithms
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Articles
    • Breast Cancer
    • GU Oncology
    • GI Oncology
    • Hematology
    • Lung Cancer
      • NSCLC
      • SCLC
  • Clinical Insights
    • Bladder Cancer
    • Lung Cancer
      • SCLC
      • NSCLC

Explore Videos, Articles & More

GU

Breaking news, expert perspectives, and real-world guidance—tailored for community care.

Power Your Practice with Smarter Oncology Insights

Home / Videos & Podcasts / New Approvals / GU
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Contact Us
  • Follow on X
  • Follow on LinkedIn

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2025 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology